United States - English - NLM (National Library of Medicine)

sungwon pharmaceutical co., ltd. - calcium carbonate (unii: h0g9379fgk) (calcium cation - unii:2m83c4r6zb) - ■ keeps teeth white and strong ■ keep the oral cavity clean ■ prevents tooth decay and bad breath caused by fluoride ■ removing plaque, preventing gingivitis and periodontitis ■ periodontal disease prevention ■ gum disease prevention for oral use only

United States - English - NLM (National Library of Medicine)

dong il pharms co., ltd. - sodium monofluorophosphate (unii: c810jcz56q) (fluoride ion - unii:q80vpu408o) - ■ keeps teeth white and strong ■ keep the oral cavity clean ■ prevents tooth decay and bad breath caused by fluoride ■ removing plaque, preventing gingivitis and periodontitis ■ periodontal disease prevention ■ gum disease prevention for oral use only

United States - English - NLM (National Library of Medicine)

dong il pharms co., ltd. - calcium carbonate (unii: h0g9379fgk) (calcium cation - unii:2m83c4r6zb) - ■ keeps teeth white and strong ■ keep the oral cavity clean ■ prevents tooth decay and bad breath caused by fluoride ■ removing plaque, preventing gingivitis and periodontitis ■ periodontal disease prevention ■ gum disease prevention for oral use only

Australia - English - Department of Health (Therapeutic Goods Administration)

noah facial recognition pty ltd - 17888 - thermometer, infrared, skin - for determining the patient's body temperature

Australia - English - Department of Health (Therapeutic Goods Administration)

cochlear ltd - 60211 - hearing aid fitting/programming application software - the software is provided on a cd or download from the csds and installed on a computer to assist a health care professional to establish the first connection between implant processor and external sound processor. to provide a patient with the appropriate gain for their hearing loss, the osia sound processor must also be programmed using this software. communication between the software and the sound processor is achieved using a hi-pro programming unit or a noahlink wireless programming unit. the cochlear osia system uses bone conduction to transmit sounds to the cochlea (inner ear) with the purpose of enhancing hearing. the osia fitting software is intended to be used by hearing care professionals to program an osia sound processor and modify hearing profiles in order to provide comfortable and usable gain for osia system recipients.

Australia - English - Department of Health (Therapeutic Goods Administration)

roche products pty ltd - trastuzumab -

New Zealand - English - Medsafe (Medicines Safety Authority)

roche products (nz) ltd - trastuzumab 150mg (excludes 4% overage);  ;  ;   - powder for infusion concentrate - 150 mg - active: trastuzumab 150mg (excludes 4% overage)       excipient: histidine histidine hydrochloride monohydrate polysorbate 20 trehalose - herceptin is indicated for the treatment of patients with metastatic breast cancer who have tumours that overexpress her2: a) as monotherapy for the treatment of those patients who have received one or more chemotherapy regimens for their metastatic disease; or b) in combination with taxanes for the treatment of those patients who have not received chemotherapy for their metastatic disease; or c) in combination with an aromatase inhibitor for the treatment of post-menopausal patients with hormone-receptor positive metastatic breast cancer.

New Zealand - English - Medsafe (Medicines Safety Authority)

roche products (nz) ltd - trastuzumab 440mg;  ;   - powder for infusion concentrate - 440 mg - active: trastuzumab 440mg     excipient: histidine histidine hydrochloride polysorbate 20 trehalose benzyl alcohol water for injection - herceptin is indicated for the treatment of patients with metastatic breast cancer who have tumours that overexpress her2: a) as monotherapy for the treatment of those patients who have received one or more chemotherapy regimens for their metastatic disease; or b) in combination with taxanes for the treatment of those patients who have not received chemotherapy for their metastatic disease; or c) in combination with an aromatase inhibitor for the treatment of post-menopausal patients with hormone-receptor positive metastatic breast cancer.

New Zealand - English - Medsafe (Medicines Safety Authority)

celltrion healthcare new zealand limited - trastuzumab 150mg - powder for infusion concentrate - 150 mg - active: trastuzumab 150mg excipient: histidine histidine hydrochloride polysorbate 20 trehalose dihydrate - herzuma is indicated for patients with metastatic breast cancer who have tumours that overexpress her2: - as monotherapy for the treatment of those patients who have received one or more chemotherapy regimens for their metastatic disease; or - in combination with taxanes for the treatment of those patients who have not received chemotherapyfor their metastatic disease; or - in combination with a aromatase inhibitor for the treatment of post-menopausal patients with hormone-receptor positive metastatic breast cancer.

New Zealand - English - Medsafe (Medicines Safety Authority)

celltrion healthcare new zealand limited - trastuzumab 440mg - powder for infusion concentrate - 440 mg - active: trastuzumab 440mg excipient: histidine histidine hydrochloride polysorbate 20 trehalose dihydrate benzyl alcohol water for injection - herzuma is indicated for patients with metastatic breast cancer who have tumours that overexpress her2: - as monotherapy for the treatment of those patients who have received one or more chemotherapy regimens for their metastatic disease; or - in combination with taxanes for the treatment of those patients who have not received chemotherapyfor their metastatic disease; or - in combination with a aromatase inhibitor for the treatment of post-menopausal patients with hormone-receptor positive metastatic breast cancer.